STUDY OF THE EFFECTS OF L. CASEI DG® (ENTEROLACTIS BABY) IN HEALTHY PRETERM AND FULL-TERM INFANTS. | MicrobiomeTrials← Back to trialsNCT07882537
STUDY OF THE EFFECTS OF L. CASEI DG® (ENTEROLACTIS BABY) IN HEALTHY PRETERM AND FULL-TERM INFANTS.
CompletedNAINTERVENTIONAL
Trial Details
Start: 2018-11-02Est. Completion: 2020-04-11
Enrollment target: 61 participants Locations- Neonatology Unit Policlinico Casilino, Roma, Roma, Italy
Other microbiome trials you might be interested in
End-stage Renal Disease (ESRD)Kidney Transplantation
Chronic kidney disease affects approximately 10% of the world population. End-stage renal disease (ESRD) is associated w…
Lyon, FranceEst. completion Oct 15, 2028
Rheumatoid Arthritis
Personalized medicine in which each patient would receive the ideal personalized treatment and regimen, holds great prom…
Montpellier, FranceCompleted Sep 16, 2026
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
This study, titled "Evaluation of the effect of regular physical exercise in women with breast cancer on adjuvant hormon…
San Sebastián de los Reyes, SpainEst. completion Oct 2026